
Joshua Joo
Examiner (ID: 11954, Phone: (571)272-3966 , Office: P/2445 )
| Most Active Art Unit | 2445 |
| Art Unit(s) | 2154, 2454, 2445 |
| Total Applications | 1186 |
| Issued Applications | 850 |
| Pending Applications | 94 |
| Abandoned Applications | 264 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6991510
[patent_doc_number] => 20050090547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains'
[patent_app_type] => utility
[patent_app_number] => 10/727655
[patent_app_country] => US
[patent_app_date] => 2003-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1992
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090547.pdf
[firstpage_image] =>[orig_patent_app_number] => 10727655
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/727655 | Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains | Dec 4, 2003 | Issued |
Array
(
[id] => 7276348
[patent_doc_number] => 20040235799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Use of a compound with a negatively charged domain of radicals for the treatment of restenosis'
[patent_app_type] => new
[patent_app_number] => 10/478962
[patent_app_country] => US
[patent_app_date] => 2003-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5300
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235799.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478962
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478962 | Use of a compound with a negatively charged domain of radicals for the treatment of restenosis | Nov 25, 2003 | Abandoned |
Array
(
[id] => 7240009
[patent_doc_number] => 20040157927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{-4-[2-(4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea'
[patent_app_type] => new
[patent_app_number] => 10/479205
[patent_app_country] => US
[patent_app_date] => 2003-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5977
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157927.pdf
[firstpage_image] =>[orig_patent_app_number] => 10479205
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/479205 | Pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{-4-[2-(4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea | Nov 25, 2003 | Abandoned |
Array
(
[id] => 7226012
[patent_doc_number] => 20040072902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Methods for inducing apoptosis and inhibiting proliferation in cancer cells'
[patent_app_type] => new
[patent_app_number] => 10/451555
[patent_app_country] => US
[patent_app_date] => 2003-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4144
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072902.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451555
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451555 | Methods for inducing apoptosis and inhibiting proliferation in cancer cells | Nov 23, 2003 | Abandoned |
Array
(
[id] => 7169252
[patent_doc_number] => 20040077609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Oral composition containing NSAIDs and essential oils'
[patent_app_type] => new
[patent_app_number] => 10/719554
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4664
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077609.pdf
[firstpage_image] =>[orig_patent_app_number] => 10719554
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/719554 | Oral composition containing NSAIDs and essential oils | Nov 20, 2003 | Abandoned |
Array
(
[id] => 5844687
[patent_doc_number] => 20060122261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => '[METHOD OF PREPARING LABDANE DITERPENE COMPOSITION, PREFERABLY ISOFORSKOLIN AND DEACETYLFORSKOLIN FROM FORSKOLIN EXTRACT AND THEIR USE FOR PROMOTING LEAN BODY MASS AND OTHER APPLICATIONS]'
[patent_app_type] => utility
[patent_app_number] => 10/707087
[patent_app_country] => US
[patent_app_date] => 2003-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3521
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122261.pdf
[firstpage_image] =>[orig_patent_app_number] => 10707087
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/707087 | [METHOD OF PREPARING LABDANE DITERPENE COMPOSITION, PREFERABLY ISOFORSKOLIN AND DEACETYLFORSKOLIN FROM FORSKOLIN EXTRACT AND THEIR USE FOR PROMOTING LEAN BODY MASS AND OTHER APPLICATIONS] | Nov 19, 2003 | Abandoned |
Array
(
[id] => 7475116
[patent_doc_number] => 20040097582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Use of a blood-flow decrease preventing agent in conjunction with insufflating gas'
[patent_app_type] => new
[patent_app_number] => 10/714980
[patent_app_country] => US
[patent_app_date] => 2003-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3294
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097582.pdf
[firstpage_image] =>[orig_patent_app_number] => 10714980
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/714980 | Use of a blood-flow decrease preventing agent in conjunction with insufflating gas | Nov 17, 2003 | Abandoned |
Array
(
[id] => 7151423
[patent_doc_number] => 20040171697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy'
[patent_app_type] => new
[patent_app_number] => 10/712546
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6731
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171697.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712546
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712546 | Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy | Nov 11, 2003 | Issued |
Array
(
[id] => 917335
[patent_doc_number] => 07323479
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-29
[patent_title] => 'Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline'
[patent_app_type] => utility
[patent_app_number] => 10/704237
[patent_app_country] => US
[patent_app_date] => 2003-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23040
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/323/07323479.pdf
[firstpage_image] =>[orig_patent_app_number] => 10704237
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/704237 | Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline | Nov 5, 2003 | Issued |
Array
(
[id] => 7368345
[patent_doc_number] => 20040092571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Pharmaceutical composition'
[patent_app_type] => new
[patent_app_number] => 10/702930
[patent_app_country] => US
[patent_app_date] => 2003-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4626
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092571.pdf
[firstpage_image] =>[orig_patent_app_number] => 10702930
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/702930 | Pharmaceutical composition | Nov 4, 2003 | Abandoned |
Array
(
[id] => 7325612
[patent_doc_number] => 20040138301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Chemical uncouplers for the treatment of obesity'
[patent_app_type] => new
[patent_app_number] => 10/699338
[patent_app_country] => US
[patent_app_date] => 2003-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 34425
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20040138301.pdf
[firstpage_image] =>[orig_patent_app_number] => 10699338
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/699338 | Chemical uncouplers for the treatment of obesity | Oct 30, 2003 | Abandoned |
Array
(
[id] => 856830
[patent_doc_number] => 07375089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-20
[patent_title] => 'Rehydration composition'
[patent_app_type] => utility
[patent_app_number] => 10/697428
[patent_app_country] => US
[patent_app_date] => 2003-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5353
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/375/07375089.pdf
[firstpage_image] =>[orig_patent_app_number] => 10697428
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/697428 | Rehydration composition | Oct 29, 2003 | Issued |
Array
(
[id] => 919772
[patent_doc_number] => 07320976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-22
[patent_title] => 'Combination of brimonidine and timolol for topical ophthalmic use'
[patent_app_type] => utility
[patent_app_number] => 10/685941
[patent_app_country] => US
[patent_app_date] => 2003-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4026
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/320/07320976.pdf
[firstpage_image] =>[orig_patent_app_number] => 10685941
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/685941 | Combination of brimonidine and timolol for topical ophthalmic use | Oct 13, 2003 | Issued |
Array
(
[id] => 7337461
[patent_doc_number] => 20040132798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => '3.7-Diazybicyclo [3.3.1] formulations as antiarrhythmic compounds'
[patent_app_type] => new
[patent_app_number] => 10/474591
[patent_app_country] => US
[patent_app_date] => 2003-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 24224
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132798.pdf
[firstpage_image] =>[orig_patent_app_number] => 10474591
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/474591 | 3.7-Diazybicyclo [3.3.1] formulations as antiarrhythmic compounds | Oct 9, 2003 | Abandoned |
Array
(
[id] => 7199944
[patent_doc_number] => 20040086578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Physiologically acceptable aqueous solutions and methods for their use'
[patent_app_type] => new
[patent_app_number] => 10/684151
[patent_app_country] => US
[patent_app_date] => 2003-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12032
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086578.pdf
[firstpage_image] =>[orig_patent_app_number] => 10684151
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/684151 | Physiologically acceptable aqueous solutions and methods for their use | Oct 9, 2003 | Abandoned |
Array
(
[id] => 7454342
[patent_doc_number] => 20040068006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Method for preventing acute renal failure'
[patent_app_type] => new
[patent_app_number] => 10/679040
[patent_app_country] => US
[patent_app_date] => 2003-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3481
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20040068006.pdf
[firstpage_image] =>[orig_patent_app_number] => 10679040
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/679040 | Method for preventing acute renal failure | Oct 2, 2003 | Abandoned |
Array
(
[id] => 5801616
[patent_doc_number] => 20060035957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Preventive or remedy for bedsore'
[patent_app_type] => utility
[patent_app_number] => 10/529721
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7482
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035957.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529721
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529721 | Preventive or remedy for bedsore | Sep 29, 2003 | Abandoned |
Array
(
[id] => 7674234
[patent_doc_number] => 20040127884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis'
[patent_app_type] => new
[patent_app_number] => 10/674290
[patent_app_country] => US
[patent_app_date] => 2003-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 27996
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127884.pdf
[firstpage_image] =>[orig_patent_app_number] => 10674290
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/674290 | Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis | Sep 28, 2003 | Abandoned |
Array
(
[id] => 7378854
[patent_doc_number] => 20040220239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions'
[patent_app_type] => new
[patent_app_number] => 10/669251
[patent_app_country] => US
[patent_app_date] => 2003-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13002
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10669251
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/669251 | Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions | Sep 24, 2003 | Abandoned |
Array
(
[id] => 7281290
[patent_doc_number] => 20040063667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Anti fibrotic agent containing sphingosine 1-phosphate receptor agonist or sphingosine 1-phospate as active ingredient'
[patent_app_type] => new
[patent_app_number] => 10/661580
[patent_app_country] => US
[patent_app_date] => 2003-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2503
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063667.pdf
[firstpage_image] =>[orig_patent_app_number] => 10661580
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/661580 | Use of sphingosine 1-phosphate as active ingredient for the treatment of pulmonary fibrosis | Sep 14, 2003 | Issued |